Continually Updated Clinical Reference
 
 
  All Sources     eMedicine     Medscape     Drug Reference     MEDLINE
 
eMedicine - Sturge-Weber Syndrome : Article by

Quick Find
Authors & Editors
Introduction
Differentials
Radiograph
CT SCAN
MRI
Nuclear Medicine
Angiography
Intervention
Acknowledgments
Multimedia
References




Patient Education
Click here for patient education.



Author: Ali Nawaz Khan, MBBS, FRCS, FRCP, FRCR, LRCP, Chairman of Medical Imaging, Professor of Radiology, NGHA, King Fahad National Guard Hospital, King Abdulaziz Medical City, Riyadh, Saudi Arabia

Ali Nawaz Khan is a member of the following medical societies:
American Institute of Ultrasound in Medicine, Radiological Society of North America, Royal College of Physicians, Royal College of Physicians and Surgeons of the United States, Royal College of Radiologists, and Royal College of Surgeons of England

Coauthor(s): Ian Turnbull, MD, Lecturer, Department of Radiology, University of Manchester; Consulting Neuroradiologist, Hope Hospital, Salford, Manchester and North Manchester Hospital; Sumaira MacDonald, MBChB, PhD, MRCP, FRCR, Lecturer, Sheffield University Medical School; Endovascular Fellow, Sheffield Vascular Institute; Riyadh Al-Okaili, MBBS, Interventional/Therapeutic and Diagnostic Neuro-Radiologist, King Abdulaziz Medical City

Editors: Charles M Glasier, MD, Professor, Departments of Radiology and Pediatrics, University of Arkansas for Medical Sciences; Chief, Magnetic Resonance Imaging, Vice-Chief, Pediatric Radiology, Arkansas Children's Hospital; Bernard D Coombs, MB, ChB, PhD, Consulting Staff, Department of Specialist Rehabilitation Services, Hutt Valley District Health Board, New Zealand; Marta Hernanz-Schulman, MD, FAAP, Professor, Radiology, Radiological Sciences, and Pediatrics, Director, Department of Pediatric Radiology, Radiologist-in-Chief, Director, Department of Diagnostic Imaging, Vanderbilt University Medical Center, Vanderbilt Children's Hospital; Robert M Krasny, MD, Consulting Staff, Department of Radiology, The Angeles Clinic and Research Institute; James G Smirniotopoulos, MD, Professor of Radiology, Neurology, and Biomedical Informatics, Chairman, Department of Radiology and Radiological Sciences, Uniformed Services University of the Health Sciences

Author and Editor Disclosure

Synonyms and related keywords: SWS, Sturge-Weber-Dimitri syndrome, encephalotrigeminal angiomatosis, trigeminal angiomatosis, meningofacial angiomatosis, encephalofacial angiomatosis, Dimitri's hemangiomatosis, Jahnke's syndrome (variant without glaucoma), Kulisher's syndrome, Krabbe's II syndrome, Lawford's syndrome (variant with glaucoma and without increased ocular pressure), meningocutaneous syndrome, neurooculocutaneous syndrome, Parkes Weber's phacomatosis, vascular encephalotrigeminal Weber-Dimitri syndrome

Background

Sturge-Weber syndrome (SWS) is a congenital disorder caused by the persistence of the transitory primordial sinusoidal plexus stage of vessel development. SWS is usually sporadic and characterized by a vascular malformation, with capillary and/or venous malformation that involve the face, choroid of the eye, and leptomeninges. The facial vascular malformation has a predilection for the distribution of the first division of the trigeminal nerve. In addition to the vascular meningeal malformation, an underlying atrophy of the cerebral hemisphere is often present. The disease process is usually unilateral. Most patients (80%) have Epilepsy, and more than 50% have a mental deficiency.1, 2, 3, 4, 5, 6, 7
 
Related eMedicine topics:
Epilepsy Surgery
EEG in Common Epilepsy Syndromes
Vascular Malformations of the Spinal Cord

Related Medscape topics:
CME Surgery Insight: Surgical Management of Epilepsy

Pathophysiology

Cranial manifestations

The pathologic lesions in SWS include vascular malformations of the face (capillary vascular malformation, also known as port-wine stain or nevus flammeus) and venous malformation or angiomas involving the leptomeninges and choroid plexus. These lesions lead to seizures, atrophy, cerebrovascular thrombosis, and dystrophic intracortical calcification. Several variants of cortical calcification have been reported; these include calcification, which is present at birth8; bilateral calcification (15%); and calcification contralateral to the facial nevus.

Cranial manifestation of SWS includes ipsilateral cerebral hemiatrophy associated with hemihypertrophy of the skull and sinuses, enlarged glomus of the choroid plexus, and abnormal myelination ipsilateral to the meningeal malformation. The hemicranium ipsilateral to the meningeal angioma may also be enlarged.1, 9, 10, 11

Many cortical veins are either absent or replaced by a few enlarged cortical veins, which drain into the dural venous sinuses. With the absence of cortical veins, venous drainage may occur via enlarged deep medullary veins into the deep venous system. Nonvisualization of dural venous sinuses is common on angiograms in patients with SWS. An increased incidence of a persistent trigeminal artery has also been reported.9, 12

Orbital manifestations

Several orbital anomalies have been described; these occur on the ipsilateral side and include glaucoma (infantile onset [buphthalmos] or onset later in life) (30%); choroidal hemangioma (71%); dilated tortuous conjunctival, episcleral, and retinal vessels; and retinal detachment.

Systemic manifestations include focal or diffuse vascular malformations, which have been described in the thyroid gland, lungs, bowel, kidneys, spleen, pancreas, and ovaries.

Intracranial vascular findings similar to those of SWS may be found in patients with other vascular syndromes, especially Klippel-Trenaunay-Weber syndrome (KTWS). However, KTWS is often associated with overgrowth of digits or limbs and peripheral vascular malformations.

Facial capillary vascular malformation (ie, port-wine stain or nevus flammeus) is common in the pediatric population. In their study of 106 patients with port-wine stains, Enjolras and associates concluded that patients with lesions located in the ophthalmic (or cranial nerve VI, trigeminal) cutaneous area are at risk for associated neuro-ocular symptoms.13, 14

Frequency

United States

SWS is a sporadic disease; its exact incidence is not known.

International

SWS is a sporadic disease; its exact incidence is not known.

Mortality/Morbidity

Reduced intellectual capacity (or developmental delay) and hemiparesis eventually develop in most patients if medical and surgical treatments are unsuccessful. Reduced intellectual capacity occurs in more than 50% of patients.

Race

SWS is a sporadic disease; no racial predilection is known.

Sex

SWS is a sporadic disease; no sex predilection is known.

Age

Seizures may occur in the first year of life (80% of cases).

Clinical Details

Most patients have a facial capillary vascular malformation lesion (ie, port-wine stain, or nevus flammeus), usually in the distribution of the first and/or second divisions of the trigeminal nerve. A first-division trigeminal distribution is associated with occipital meningeal involvement; a second-division distribution, with parietal meningeal involvement; and a third-division distribution, with frontal meningeal involvement.

About 80% of affected persons have focal seizures involving the side contralateral to the nevus, usually in their first year of life; contralateral hemiplegia; homonymous hemianopia; cortical blindness; contralateral atrophy of limbs; and/or a contralateral hemisensory deficit. Approximately half of the patients have developmental delay. Ocular manifestations, such as glaucoma, buphthalmos, coloboma of the iris, retinal detachment, and strabismus, may be present. The association of a coloboma may be incidental.15

A rare form of bilateral neonatal SWS has been described. The CT and MRI features of cortical calcification and meningeal angiomatosis are typical of SWS but unusual in children younger than 1 year. Yeakley et al have described a child presenting with both of these features, which occurred bilaterally in the neonatal period.8 A rare association with KTWS has been described in cases in which clinical criteria diagnostic of both SWS and KTWS were present.

 

Preferred Examination

Examinations for SWS include the following: plain skull radiography, CT, MRI, angiography, and nuclear medicine studies.16, 17, 18, 19, 20, 21, 22, 23, 24, 25

CT is more sensitive then plain skull radiography and MRI in the detection subcortical calcifications. However MRI with contrast is probably the best imaging test. It is superior to CT in the demonstration of abnormal myelination, and it is more sensitive in the demonstration of leptomeningeal enhancement, particularly in the presence of dense cortical calcification on CT scans. In addition, orbital associated malformations are well depicted on contrast-enhanced orbital MRI.

Limitations of Techniques

Calcification may not be detectable in individuals younger than 2 years. Other causes of gyriform intracranial calcification cannot always be differentiated from those found in SWS.
 
MRI is expensive, it is less widely available, and patients may experience claustrophobia. MRI is contraindicated in patients with certain types of cardiac pacemakers and ferromagnetic prostheses.
 
Klippel-Trenaunay-Weber syndrome and Wyburn-Mason syndrome may cause similar angiographic appearances.

Cerebral perfusion defects and areas of hypometabolism are seen with positron emission tomography (PET) in a variety of epileptogenic foci.

 



Other Problems to Be Considered

Klippel-Trenaunay syndrome
Wyburn-Mason syndrome

Other causes of gyriform intracranial calcification are rare but may include cerebral infarction, meningitis and encephalitis, skull irradiation, meningioangiomatosis, celiac disease, and leukemia after the intrathecal administration of methotrexate.



Findings

Plain skull radiographs may show ipsilateral skull-table and orbital thickening, elevation of the sphenoid wing and petrous ridge, and enlarged ipsilateral paranasal sinuses and mastoid air cells due to underlying ipsilateral cerebral atrophy. Plain radiographs of the skull in older children and adults may reveal asymmetry, with a smaller hemicranium on the ipsilateral side. Rarely, ipsilateral enlargement of the hemicranium occurs secondary to the vascular malformation. The most striking feature is the presence of tramline gyriform patterns of intracranial calcification in the subcortical region, primarily in the parietal and occipital regions.

Calcification usually affects children older than 2 years, although calcification has been described in neonates. The calcification is bilateral in 20% of patients.

 

Degree of Confidence

Skull radiographs usually do not demonstrate calcifications until patients are older than 2 years. The increased sensitivity of CT allows earlier demonstration of calcifications.

False Positives/Negatives

Other causes of gyriform intracranial calcification can lead to a false-positive diagnosis. The detection of calcifications in patients younger than 2 years is unusual with plain radiography.



Findings

CT scans show the tramline gyriform calcification of apposing gyri that underlies the contrast-enhancing leptomeningeal vascular malformation. Cortical enhancement may be difficult to appreciate on CT when cortical calcification is dense. The subjacent white matter may be hypoattenuating on CT scans. The ipsilateral choroid plexus may be enlarged. Enlarged transcortical (medullary) veins are frequently associated with an enlarged choroid glomus.

Other features on CT scans include ipsilateral cortical atrophy, enlargement of the ipsilateral ventricle, and loss of volume of the ipsilateral cranial cavity. Occasionally, the hemicranium is enlarged on the ipsilateral side, with associated enlargement of the cerebrospinal fluid (CSF) space.

 

Degree of Confidence

CT is more sensitive than skull radiography and MRI in the detection subcortical calcifications, and detection is sometimes possible in patients younger than 2 years.

False Positives/Negatives

Other causes of gyriform intracranial calcification could lead to a false-positive diagnosis.



Findings

MRI reveals a pial, enhancing, angiomatous malformation, often in the occipital or posterior temporoparietal region ipsilateral to the facial angioma. MRI demonstrates atrophy of the cerebral hemisphere subjacent to the leptomeningeal angioma, with small gyri and enlarged adjacent sulci. Subtle atrophy is frequently more obvious on MRIs than on CT scans. On T2-weighted images, the angioma appears as a hyperintense leptomeningeal thickening. In patients with choroidal angiomas, high-resolution, T1-weighted, fat-suppressed, enhanced images show choroidal enhancement.

Gadolinium enhancement improves visualization of the angiomatous malformation. Calcification in the underlying cortex is not as evident as on CT scans, but it does not mask enhancement of the underlying angiomatous malformation, which can be a problem with CT. As in contrast-enhanced CT, the glomus of the choroid plexus may be enlarged, and enlarged draining transcortical veins may be present in the involved cerebral hemisphere. The overlying superficial cortical veins are reduced in size and number, with a prominent deep collateral venous system.

Abnormally low signal intensity from the involved cortex may result from dystrophic calcification or from abnormal iron deposition in the cortex. Abnormal myelination has been described in association with SWS; myelination may be delayed or deficient in some patients and accelerated in others.

Susceptibility-weighted imaging (SWI) is a 3-dimensional gradient-echo MR imaging technique with phase post-processing. SWI is useful in accentuating the paramagnetic properties of blood products, intravascular venous deoxygenated blood, and extravascular blood products. It is effective in the presence of other substances such as iron, calcification, and air. The technique has been used for a variety of pediatric neurologic disorders, including vascular malformations such as cavernous angiomas, telangiectasias, and pial angiomas associated with Sturge-Weber syndrome, as well as the depiction of calcification in intracranial lesions. SWI has the potential to provide additional diagnostic and prognostic information that may improve the care and outcome of affected children.

Quantitative brain MR spectroscopy (MRS) and diffusion tensor imaging (DTI) have been used in the characterization of SWS. Differences have been recorded between the abnormal cerebral cortex and the normal contralateral normal cerebral cortex. A choline increase and N-acetylaspartate decrease are observed in a pathologic cortex, while an unaffected cerebral cortex shows no change in the DTI parameters. These changes in the pathologic cortical gray matter in SWS patients probably reflect neuronal loss or dysfunction and demyelination as a result of recurrent seizures.26

Physiologic alterations in SWS can be assessed by using MR perfusion imaging (PWI) and proton spectroscopic imaging (MRSI).  PWI changes in SWS indicate cerebral hypoperfusion predominantly due to impaired venous drainage, with only the most severely affected regions showing arterial perfusion deficiency. The severity of cerebral hypoperfusion correlates well with neuronal loss/dysfunction, which is reflected in the severity of neurologic symptoms and disability. The highest correlation is found with the degree of hemiparesis. These parameters may be useful in quantifying disease severity.27 

Blood-oxygen-level-dependent (BOLD) MR venography has been shown to identify leptomeningeal internal veins in a 4-month-old with SWS when other MR sequences failed to show any abnormality. Follow-up MRI after the first seizure at the age of 12 months demonstrated strong leptomeningeal enhancement, while BOLD venography revealed abnormal medullary and subependymal veins, as well as deep venous structures. At the time of the second MR scan signs of cerebral atrophy and calcifications were apparent on CT. The report shows that BOLD venography may allow early diagnosis of venous anomalies in SWS.28

Gadolinium-based contrast agents (gadopentetate dimeglumine [Magnevist], gadobenate dimeglumine [MultiHance], gadodiamide [Omniscan], gadoversetamide [OptiMARK], gadoteridol [ProHance]) have recently been linked to the development of nephrogenic systemic fibrosis (NSF) or nephrogenic fibrosing dermopathy (NFD). For more information, see the eMedicine topic Nephrogenic Fibrosing Dermopathy. The disease has occurred in patients with moderate to end-stage renal disease after being given a gadolinium-based contrast agent to enhance MRI or MRA scans.

As of late December 2006, the FDA had received reports of 90 such cases of NSF/NFD. Worldwide, over 200 cases have been reported, according to the FDA. NSF/NFD is a debilitating and sometimes fatal disease. Characteristics include red or dark patches on the skin; burning, itching, swelling, hardening, and tightening of the skin; yellow spots on the whites of the eyes; joint stiffness with trouble moving or straightening the arms, hands, legs, or feet; pain deep in the hip bones or ribs; and muscle weakness. For more information, see the FDA Public Health Advisory or Medscape.

Degree of Confidence

Although MRI is not as good as CT in depicting calcification, it is superior to CT in the demonstration of abnormal myelination. MRI is much more sensitive in the demonstration of leptomeningeal enhancement, particularly in the presence of dense cortical calcification on CT scans. Choroidal lesions are well depicted on high-resolution contrast-enhanced orbital MRIs.

False Positives/Negatives

SWS must be differentiated from other neurocutaneous disorders, although correlation of the intracranial findings with the clinical characteristics is usually diagnostic. Statistically, most patients with facial capillary malformations (port-wine stains) do not have SWS. In addition, some patients with classic intracranial findings of SWS have no facial abnormalities.



Findings

Abnormal cerebrovenous drainage is associated with ischemia, hypoxia, and glucose deprivation, which can account for progressive neurologic deterioration in SWS. Single-photon emission CT (SPECT), technetium-99m hexamethylpropyleneamine oxime (HMPAO) scanning, and fluorodeoxyglucose (FDG) PET scans show diminished perfusion and reduced glucose metabolism in the affected cerebral hemisphere.29

Approximately 50% of the patients with SWS have bihemispheric disease when they are examined with functional imaging, which reveals abnormal perfusion and glucose metabolism. Widespread abnormalities of cerebral perfusion and glucose metabolism might explain the high prevalence of developmental delay associated with SWS. Hypoperfusion of the involved cerebral hemisphere usually appears in patients older than 1 year.

SPECT depicts cerebral blood flow asymmetry in infants with SWS, which tends to shift with age. The cortex involved in the vascular malformation is hyperperfused during the first year of life, before the first seizures occur. The characteristic hypoperfusion appears after 1 year of age, even in patients without epilepsy.30

Degree of Confidence

Technetium-99m HMPAO imaging is a useful addition to the examination when delineation of the full extent of the abnormality is of particular relevance (eg, before surgery). Technetium-99m imaging is more likely to depict areas of hypoperfusion, which represent ischemic regions; these areas may act as epileptogenic foci and may not be detected by using CT or MRI.

False Positives/Negatives

Cerebral perfusion defects and areas of hypometabolism are seen on PET images in epileptogenic foci secondary to multiple underlying abnormalities.



Findings

Although SWS is usually categorized with venous malformations, it is an extensive capillary and venous malformation that affects 1 or sometimes both cerebral hemispheres. Cerebral angiograms show early capillary blush in the areas involved with the pial vascular malformation associated with abnormally large veins in the subependymal and periventricular regions. Enlarged deep medullary veins that drain deep to the subependymal veins are present. The superficial cortical veins in the region of the dystrophic calcification have markedly slow flow as a result of venous thrombosis, but most of the cortical veins are largely absent on the affected side. Rarely, high-flow shunting of arteriovenous malformations are seen.

Venous drainage occurs via bizarre, enlarged deep medullary veins into the deep venous system or via a few patent enlarged cortical veins into the dural venous sinus. The deep veins and dural venous sinus are often not visualized in these patients. Whether the absent veins are congenitally aplastic or occluded as a result of thrombosis is not certain.

Some authorities advocate antiplatelet therapy in SWS, believing that clinical exacerbations may be the result of progressive venous thrombosis, although this has never been clearly documented with conventional angiography. However, progressive dural venous occlusion has been documented with magnetic resonance venography in an infant with SWS, although no luminal thrombus was evident on spin-echo images. So far, observations in SWS do little to clarify the issue of congenital versus acquired abnormality of the intracranial venous system.

Other vascular abnormalities seen with SWS include arterial occlusion (rare), segmental venous ectasia, and absent or luminal irregularities and deformities of the deep veins.

 

Degree of Confidence

In light of an appropriate history, the angiographic appearances of SWS can be fairly characteristic, although the role of angiography in the management of SWS is decreasing. However, in patients with medically unresponsive seizures, resection of brain deep to the angioma is sometimes undertaken. In these patients, the identification of large diploic vessels by using angiography can help avoid a difficult craniotomy.

False Positives/Negatives

Klippel-Trenaunay-Weber syndrome  and Wyburn-Mason syndrome may cause similar angiographic appearances.



Cerebral lobectomy may be considered in some patients. In cases with severe drug-refractory focal epilepsy caused by SWS, promising results have been achieved with hemispherectomy.31

Devlin and associates described the clinical course and outcomes in 33 children who underwent hemispherectomy and concluded that the optimal timing of surgery with respect to age at presentation and the influence of the underlying pathology are only slowly emerging. At surgery, their patients were aged 0.33-17 years.32

Vining and associates from John-Hopkins hospital reported their experience with 58 children after hemispherectomy. They concluded that early surgery relieves the burden of constant seizures and allows the child to return to a more-normal life.33 Kossoff et al concluded that the patient's age at surgery does not have an adverse effect on either seizure or cognitive outcomes.34

Medical/Legal Pitfalls

  • SWS is a clinical diagnosis in children presenting with developmental delay and hemiparesis, which eventually develop in most patients if medical and surgical treatment are unsuccessful.
  • The radiologic diagnosis is usually made with a high index of clinical suspicion. In diagnosing SWS, the clinician must have supporting imaging findings that have been correctly interpreted.
  • Early surgery relieves the patient from the burden of constant seizures and allows the child to return to a more-normal life.

See also the Medscape topic Medical Malpractice and Legal Issues.



The authors and editors would like to thank Ramesh Chandra Raja, MBBCH, for his contributions to this article.



Media file 1:  Plain lateral skull radiograph demonstrates the typical gyriform pattern of cortical calcification (arrows) in the occipital region.
Click to see larger pictureClick to see detailView Full Size Image
Media type:  X-RAY

Media file 2:  Contrast-enhanced CT scan in the same patient as in Image 1 shows intense enhancement of the angiomatous malformation and atrophy of the ipsilateral hemisphere.
Click to see larger pictureClick to see detailView Full Size Image
Media type:  CT

Media file 3:  Axial nonenhanced CT scan shows left hemiatrophy of the cerebral cortex and typical gyral calcification.
Click to see larger pictureClick to see detailView Full Size Image
Media type:  CT

Media file 4:  Axial T1-weighted gadolinium-enhanced MRI in a 5-year-old child with a right-sided facial nevus and a history of focal fits. Image shows intense pial enhancement due to angiomatous malformation and subjacent cerebral atrophy.
Click to see larger pictureClick to see detailView Full Size Image
Media type:  MRI

Media file 5:  Axial contrast-enhanced CT scan through the occipital horns of the lateral ventricles shows right cerebral atrophy and an enlarged right choroid plexus in a patient with Sturge-Weber syndrome (see also Image 6).
Click to see larger pictureClick to see detailView Full Size Image
Media type:  CT

Media file 6:  Axial T1-weighted gadolinium-enhanced MRI through the occipital horns of the lateral ventricles in the same patient as in Image 5. MRI shows right cerebral atrophy, an enhancing right occipital cortex, and an enlarged right choroid plexus in a patient with Sturge-Weber syndrome. Image also depicts the enhancement of the malformation more clearly than does the CT scan (see Image 5).
Click to see larger pictureClick to see detailView Full Size Image
Media type:  MRI

Media file 7:  Plain radiographs of the skull in a 16-year-old male adolescent shows asymmetry of the skull with a smaller hemicranium on the affected side. Note the underlying tramline gyriform intracranial calcification in the subcortical occipital region.
Click to see larger pictureClick to see detailView Full Size Image
Media type:  X-RAY



  1. Cure JK, Van Tassel P. Congenital and acquired abnormalities of the dural venous sinuses. Semin Ultrasound CT MR. Dec 1994;15(6):520-39. [Medline].
  2. Kihiczak NI, Schwartz RA, Jozwiak S. Sturge-Weber syndrome. Cutis. Mar 2000;65(3):133-6. [Medline].
  3. Maria BL, Neufeld JA, Rosainz LC. High prevalence of bihemispheric structural and functional defects in Sturge-Weber syndrome. J Child Neurol. Dec 1998;13(12):595-605. [Medline].
  4. Maria BL, Neufeld JA, Rosainz LC. Central nervous system structure and function in Sturge-Weber syndrome: evidence of neurologic and radiologic progression. J Child Neurol. Dec 1998;13(12):606-18. [Medline].
  5. Pascual-Castroviejo I, Diaz-Gonzalez C, Garcia-Melian RM. Sturge-Weber syndrome: study of 40 patients. Pediatr Neurol. Jul-Aug 1993;9(4):283-8. [Medline].
  6. Powell J. Update on hemangiomas and vascular malformations. Curr Opin Pediatr. Oct 1999;11(5):457-63. [Medline].
  7. Romanowski CA, Cavallin LI. Tuberous sclerosis, von Hippel-Lindau disease, Sturge-Weber syndrome. Hosp Med. Mar 1998;59(3):226-31. [Medline].
  8. Yeakley JW, Woodside M, Fenstermacher MJ. Bilateral neonatal Sturge-Weber-Dimitri disease: CT and MR findings. AJNR Am J Neuroradiol. Jul-Aug 1992;13(4):1179-82. [Medline].
  9. Duncan DB, Herholz K, Pietrzyk U. Regional cerebral blood flow and metabolism in Sturge-Weber disease. Clin Nucl Med. Jun 1995;20(6):522-3. [Medline].
  10. Herron J, Darrah R, Quaghebeur G. Intra-cranial manifestations of the neurocutaneous syndromes. Clin Radiol. Feb 2000;55(2):82-98. [Medline].
  11. Ku PK, Kew J, van Hasselt CA. Paranasal sinus enlargement in Sturge-Weber syndrome. J Laryngol Otol. Feb 1999;113(2):177-8. [Medline].
  12. Fishman MA, Baram TZ. Megalencephaly due to impaired cerebral venous return in a Sturge-Weber variant syndrome. J Child Neurol. Apr 1986;1(2):115-8. [Medline].
  13. Enjolras O, Riche MC, Merland JJ. Facial port-wine stains and Sturge-Weber syndrome. Pediatrics. Jul 1985;76(1):48-51. [Medline].
  14. Gururaj AK, Sztriha L, Johansen J. Sturge-Weber syndrome without facial nevus: a case report and review of the literature. Acta Paediatr. Jun 2000;89(6):740-3. [Medline].
  15. Hooshang T, Lachman RS. Sturge-Weber syndrome. In: Radiolgy of Syndromes, Metabolic Disorders and Skeletal Dysplasias. 1996: 437-74.
  16. Aguiar PH, Liu CW, Leitao H. MR and CT imaging in the Dyke-Davidoff-Masson syndrome. Report of three cases and contribution to pathogenesis and differential diagnosis. Arq Neuropsiquiatr. Dec 1998;56(4):803-7. [Medline].
  17. Bar-Sever Z, Connolly LP, Barnes PD. Technetium-99m-HMPAO SPECT in Sturge-Weber syndrome. J Nucl Med. Jan 1996;37(1):81-3. [Medline].
  18. Griffiths PD, Boodram MB, Blaser S. 99mTechnetium HMPAO imaging in children with the Sturge-Weber syndrome: a study of nine cases with CT and MRI correlation. Neuroradiology. Mar 1997;39(3):219-24. [Medline].
  19. Marti-Bonmati L, Menor F, Mulas F. The Sturge-Weber syndrome: correlation between the clinical status and radiological CT and MRI findings. Childs Nerv Syst. Apr 1993;9(2):107-9. [Medline].
  20. Sener RN, Jinkins JR. MR of craniocerebral hemiatrophy. Clin Imaging. Apr-Jun 1992;16(2):93-7. [Medline].
  21. Sugama S, Yoshimura H, Ashimine K. Enhanced magnetic resonance imaging of leptomeningeal angiomatosis. Pediatr Neurol. Oct 1997;17(3):262-5. [Medline].
  22. Tong KA, Ashwal S, Obenaus A, Nickerson JP, Kido D, Haacke EM. Susceptibility-Weighted MR Imaging: A Review of Clinical Applications in Children. AJNR Am J Neuroradiol. Oct 9 2007;[Medline].
  23. Jordan LC, Wityk RJ, Dowling MM, Dejong MR, Comi AM. Transcranial Doppler ultrasound in children with sturge-weber syndrome. J Child Neurol. Feb 2008;23(2):137-43. [Medline].
  24. Juhasz C, Lai C, Behen ME, Muzik O, Helder EJ, Chugani DC. White matter volume as a major predictor of cognitive function in Sturge-Weber syndrome. Arch Neurol. Aug 2007;64(8):1169-74. [Medline].
  25. Hatfield LA, Crone NE, Kossoff EH, Ewen JB, Pyzik PL, Lin DD. Quantitative EEG asymmetry correlates with clinical severity in unilateral Sturge-Weber syndrome. Epilepsia. Jan 2007;48(1):191-5. [Medline].
  26. Sijens PE, Gieteling EW, Meiners LC, Sival DA, Potze JH, Irwan R. Diffusion tensor imaging and magnetic resonance spectroscopy of the brain in a patient with Sturge-Weber syndrome. Acta Radiol. Nov 2006;47(9):972-6. [Medline].
  27. Lin DD, Barker PB, Hatfield LA, Comi AM. Dynamic MR perfusion and proton MR spectroscopic imaging in Sturge-Weber syndrome: correlation with neurological symptoms. J Magn Reson Imaging. Aug 2006;24(2):274-81. [Medline].
  28. Mentzel HJ, Dieckmann A, Fitzek C, Brandl U, Reichenbach JR, Kaiser WA. Early diagnosis of cerebral involvement in Sturge-Weber syndrome using high-resolution BOLD MR venography. Pediatr Radiol. Jan 2005;35(1):85-90. [Medline].
  29. Chugani HT. The role of PET in childhood epilepsy. J Child Neurol. Oct 1994;9 Suppl 1:S82-8. [Medline].
  30. Pinton F, Chiron C, Enjolras O. Early single photon emission computed tomography in Sturge-Weber syndrome. J Neurol Neurosurg Psychiatry. Nov 1997;63(5):616-21. [Medline].
  31. Tuxhorn IE, Pannek HW. Epilepsy surgery in bilateral Sturge-Weber syndrome. Pediatr Neurol. May 2002;26(5):394-7. [Medline].
  32. Devlin AM, Cross JH, Harkness W. Clinical outcomes of hemispherectomy for epilepsy in childhood and adolescence. Brain. Mar 2003;126(Pt 3):556-66. [Medline].
  33. Vining EP, Freeman JM, Pillas DJ. Why would you remove half a brain? The outcome of 58 children after hemispherectomy-the Johns Hopkins experience: 1968 to 1996. Pediatrics. Aug 1997;100(2 Pt 1):163-71. [Medline].
  34. Kossoff EH, Buck C, Freeman JM. Outcomes of 32 hemispherectomies for Sturge-Weber syndrome worldwide. Neurology. Dec 10 2002;59(11):1735-8. [Medline].
  35. Kochar DK, Jain N, Sharma BV. Dyke-Davidoff Masson syndrome : neuroimage. Neurol India. Dec 2001;49(4):417. [Medline].
  36. Sener RN. Growing skull fracture in a patient with cerebral hemiatrophy. Pediatr Radiol. 1995;25(1):64-5. [Medline].
  37. Tasdemir HA, Incesu L, Yazicioglu AK. Dyke-Davidoff-Masson syndrome. Clin Imaging. Jan-Feb 2002;26(1):13-7. [Medline].
  38. Winkler DT, Probst A, Wegmann W. Dyke Davidoff Masson syndrome with crossed cerebellar atrophy: an old disease in a new millenium. Neuropathol Appl Neurobiol. Oct 2001;27(5):403-5. [Medline].
  39. Yamazaki K, Hirata K. [Dyke-Davidoff-Masson syndrome]. Ryoikibetsu Shokogun Shirizu. 2000;(30 Pt 5):177-8. [Medline].

Sturge-Weber Syndrome excerpt

Article Last Updated: Feb 26, 2008